Bharat Biotech asked to provide more data on Covid-19 vaccine Covaxin for children aged below 12, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its Covid-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. This development comes after the SEC discussed recommendations for the restricted emergency of Covaxin in children in 2-12 age group., The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its Covid-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said. This development comes after the SEC discussed recommendations for the restricted emergency of Covaxin in children in 2-12 age group., , Read More